Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally induced septic shock in rats
In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by s...
Saved in:
Published in | Anesth Analg Vol. 99; no. 1; pp. 212 - 220 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Ovid Technologies (Wolters Kluwer Health)
01.07.2004
International Anesthesia Research Society Lippincott |
Subjects | |
Online Access | Get full text |
ISSN | 0003-2999 |
DOI | 10.1213/01.ane.0000118111.94913.22 |
Cover
Abstract | In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groupscontrol, sham, CLP, and CLP + the selective iNOS inhibitor l-N 6-(1-iminoethyl)-lysine (l-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 hcontrol, 0.3 ± 0.05; sham, 0.3 ± 0.1; CLP, 1.3 ± 0.08*; CLP + l-NIL, 0.33 ± 0.1 fmol · mg−1 · min−1; at 24 hcontrol, 0.27 ± 0.08; sham, 0.31 ± 0.1; CLP, 1.0 ± 0.3*; CLP + l-NIL, 0.34 ± 0.1 fmol · mg−1 · min−1; mean ± sd; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 hcontrol, 6.7 ± 0.4; sham, 6.7 ± 0.5; CLP, 11.2 ± 2.8*; CLP + l-NIL, 7.52 ± 0.5 densitometric units; means ± sd; *P < 0.01). In contrast, in both the CLP and CLP + l-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction. |
---|---|
AbstractList | In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groupscontrol, sham, CLP, and CLP + the selective iNOS inhibitor l-N 6-(1-iminoethyl)-lysine (l-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 hcontrol, 0.3 ± 0.05; sham, 0.3 ± 0.1; CLP, 1.3 ± 0.08*; CLP + l-NIL, 0.33 ± 0.1 fmol · mg−1 · min−1; at 24 hcontrol, 0.27 ± 0.08; sham, 0.31 ± 0.1; CLP, 1.0 ± 0.3*; CLP + l-NIL, 0.34 ± 0.1 fmol · mg−1 · min−1; mean ± sd; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 hcontrol, 6.7 ± 0.4; sham, 6.7 ± 0.5; CLP, 11.2 ± 2.8*; CLP + l-NIL, 7.52 ± 0.5 densitometric units; means ± sd; *P < 0.01). In contrast, in both the CLP and CLP + l-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction. In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction. In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction. |
Author | KADOI Y |
AuthorAffiliation | Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan |
AuthorAffiliation_xml | – name: Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan |
Author_xml | – sequence: 1 givenname: Yuji surname: Kadoi fullname: Kadoi, Yuji organization: Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan – sequence: 2 givenname: Fumio surname: Goto fullname: Goto, Fumio |
BackLink | https://cir.nii.ac.jp/crid/1573105976154161536$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15913235$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15281532$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkctu1DAUhrMoohd4BWQhYEUGX5OYFVVVWqQKFsA6cuwTxtSxB9uhndfhSXFmBhWxwpJt2f7O__ucc1od-eChqp4TvCKUsDeYrJSHFS6DkI4QspJcErai9Kg6KZesplLK4-o0pe8Lg7vmcXVMBO2IYPSk-vUZHOhsfwKy3szaDg6QtzlajcK9Ncv12g422-CRVh5FSDlEQGuYgtl6NVmdXqNhzsgESMiHjOy0iaEIephjcOGb1cohs03j7PVOx3oE9xuIdgKflXPbvTcYlGCTi3NaB327YFHl9KR6NCqX4OlhP6u-vr_8cnFd33y6-nBxflNrTiSteccHTBvejYMcRdsNDAsztmzElFLDpCkPHDMjGyzIIIE0THJDRlB6VA0V7Kx6tdctv_8xlzT7ySYNzpUChzn1TdMK3Ha8gM8O4DxMYPpNSUTFbf-nqgV4eQBUKrmPUXlt019c6RBli-PbPadjSCnC-IDgfmlvj0l__vGyf2hvv2tvTxeTd_8Ea5vVUt8clXX_J8H3EnfBZYjp1s13EPs1KJfXuwgsmKwpxhy35VCXyZewF_swb20xXVYiWkawkG1DBCdlYQ37DZPbywI |
CODEN | AACRAT |
CitedBy_id | crossref_primary_10_1016_j_ccc_2007_10_001 crossref_primary_10_1097_CPM_0b013e3181a3a4bf crossref_primary_10_1186_2110_5820_3_15 crossref_primary_10_2217_fnl_10_62 crossref_primary_10_1186_s12871_021_01436_0 crossref_primary_10_1016_j_anrea_2019_03_002 crossref_primary_10_1016_j_biopha_2018_09_162 crossref_primary_10_1016_j_exer_2005_08_011 crossref_primary_10_1007_s00540_010_0934_1 crossref_primary_10_1097_CCM_0b013e3181760c4b crossref_primary_10_1007_s11910_016_0623_z crossref_primary_10_1007_s13546_010_0118_x crossref_primary_10_1586_eri_12_159 crossref_primary_10_1097_WCO_0b013e32832b3101 crossref_primary_10_1007_s00134_007_0622_2 crossref_primary_10_1016_j_ejps_2015_01_001 crossref_primary_10_1038_jcbfm_2009_215 crossref_primary_10_1016_j_freeradbiomed_2011_06_012 crossref_primary_10_1111_nyas_13985 crossref_primary_10_1586_ers_09_39 crossref_primary_10_1016_j_pharmthera_2009_05_005 crossref_primary_10_23736_S0375_9393_20_13826_4 crossref_primary_10_1176_jnp_23_3_jnp237 crossref_primary_10_1002_ardp_200800192 crossref_primary_10_1007_s10753_011_9359_8 crossref_primary_10_1097_CCM_0b013e3181b6ed58 crossref_primary_10_1097_CCM_0000000000000301 crossref_primary_10_1016_j_bbi_2019_10_012 crossref_primary_10_1097_SHK_0b013e31804d452d crossref_primary_10_1111_j_1399_6576_2007_01573_x crossref_primary_10_1093_bja_aei106 crossref_primary_10_1007_s00540_006_0428_3 crossref_primary_10_1016_j_brainres_2010_07_049 crossref_primary_10_1097_01_CCM_0000187010_14426_CC crossref_primary_10_1002_ame2_12167 |
Cites_doi | 10.1164/ajrccm.161.6.9812004 10.1002/jnr.490400214 10.1152/ajpcell.1998.275.2.C416 10.1097/00024382-199610000-00004 10.1016/S0306-3623(96)00410-7 10.1097/00000539-200103000-00025 10.1097/00003246-200008000-00057 10.1097/00003246-199302001-00005 10.1006/jsre.1996.0153 10.1152/ajpcell.1996.271.5.C1424 10.1172/JCI119551 10.1016/0361-9230(96)00159-1 10.1111/j.1476-5381.1996.tb15397.x 10.1159/000054305 10.1016/0022-4804(80)90037-2 10.1006/jsre.2002.6524 10.1021/jm00049a007 10.1038/375408a0 10.1016/S0006-8993(99)01124-5 10.1097/00024382-199608000-00001 10.1080/10715760290032557 10.1097/00024382-200116040-00013 10.1038/nm0596-581 10.1097/00003246-199602000-00020 10.1046/j.1471-4159.2000.0752144.x |
ContentType | Journal Article |
Copyright | International Anesthesia Research Society 2004 INIST-CNRS |
Copyright_xml | – notice: International Anesthesia Research Society – notice: 2004 INIST-CNRS |
DBID | RYH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1213/01.ane.0000118111.94913.22 |
DatabaseName | CiNii Complete CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EndPage | 220 |
ExternalDocumentID | 15281532 15913235 10_1213_01_ANE_0000118111_94913_22 00000539-200407000-00042 30012760614 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .-D .55 .GJ .XZ .Z2 01R 026 0R~ 1CY 1J1 23M 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABKPX ABOCM ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACLED ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFMFG AFNMH AFSOK AFUWQ AGINI AHOMT AHQNM AHQVU AHRYX AHVBC AHXIK AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJRGT AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK BS7 C1A C45 CS3 DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI L-C L7B M18 MZP N4W N9A N~7 N~B N~M O9- OAG OAH OB4 OCUKA ODA ODMTH OHYEH OK1 OL1 OLG OLH OLL OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PONUX R58 RIG RLZ RYH S4R S4S TEORI TR2 TSPGW V2I VVN W3M W8F WOQ WOW X3V X3W X7M XXN XYM YFH YOC YQJ ZFV ZGI ZXP ZZMQN AAYXX ADSXY CITATION IQODW ACIJW AWKKM CGR CUY CVF DIK ECM EIF NPM OJAPA OLW PKN 7X8 ADKSD |
ID | FETCH-LOGICAL-c4192-484b02648fb9f578b305df73f0222d39d8fb403d96051b9e16394d1feacfa6253 |
ISSN | 0003-2999 |
IngestDate | Mon Sep 08 16:31:05 EDT 2025 Wed Feb 19 02:33:59 EST 2025 Mon Jul 21 09:13:28 EDT 2025 Thu Apr 24 22:53:05 EDT 2025 Tue Aug 12 03:53:07 EDT 2025 Fri May 16 03:50:31 EDT 2025 Thu Jun 26 21:56:59 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Infection Vertebrata Mammalia Rat Animal Nitric oxide Rodentia Anesthesia Hemodynamics |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4192-484b02648fb9f578b305df73f0222d39d8fb403d96051b9e16394d1feacfa6253 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15281532 |
PQID | 66750784 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_66750784 pubmed_primary_15281532 pascalfrancis_primary_15913235 crossref_primary_10_1213_01_ANE_0000118111_94913_22 crossref_citationtrail_10_1213_01_ANE_0000118111_94913_22 wolterskluwer_health_00000539-200407000-00042 nii_cinii_1573105976154161536 |
PublicationCentury | 2000 |
PublicationDate | 2004-July-01 |
PublicationDateYYYYMMDD | 2004-07-01 |
PublicationDate_xml | – month: 07 year: 2004 text: 2004-July-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Anesth Analg |
PublicationTitleAlternate | Anesth Analg |
PublicationYear | 2004 |
Publisher | Ovid Technologies (Wolters Kluwer Health) International Anesthesia Research Society Lippincott |
Publisher_xml | – name: Ovid Technologies (Wolters Kluwer Health) – name: International Anesthesia Research Society – name: Lippincott |
References | Thiemermann (R5-42-20110423) 1997; 29 Van Dam (R9-42-20110423) 1995; 40 Beckman (R12-42-20110423) 1996; 271 Schwartz (R19-42-20110423) 1997; 100 Satta (R24-42-20110423) 1998; 67 Vincent (R6-42-20110423) 2000; 161 Strunk (R14-42-20110423) 2001; 92 Javeshghani (R16-42-20110423) 2001; 16 Wichterman (R13-42-20110423) 1980; 29 Harada (R11-42-20110423) 1999; 821 Papadopoulos (R25-42-20110423) 2000; 28 Szabo (R4-42-20110423) 1996; 6 Liu (R27-42-20110423) 2000; 75 Kadoi (R2-42-20110423) 1996; 24 Szabo (R7-42-20110423) 1996; 41 Baechtold (R8-42-20110423) 2001; 16 Wong (R10-42-20110423) 1996; 2 Ruetten (R23-42-20110423) 1996; 118 Voigt (R26-42-20110423) 2002; 36 Gunnett (R22-42-20110423) 1998; 275 Moore (R15-42-20110423) 1994; 23 Ghosh (R1-42-20110423) 1993; 21 Vromen (R20-42-20110423) 1996; 6 Kadoi (R17-42-20110423) 2002; 108 Wei (R21-42-20110423) 1995; 375 Kadoi (R3-42-20110423) 1996; 61 |
References_xml | – volume: 161 start-page: 1781 year: 2000 ident: R6-42-20110423 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.161.6.9812004 – volume: 40 start-page: 251 year: 1995 ident: R9-42-20110423 publication-title: J Neurosci Res doi: 10.1002/jnr.490400214 – volume: 275 start-page: H416 year: 1998 ident: R22-42-20110423 publication-title: Am J Physiol doi: 10.1152/ajpcell.1998.275.2.C416 – volume: 6 start-page: 248 year: 1996 ident: R20-42-20110423 publication-title: Shock doi: 10.1097/00024382-199610000-00004 – volume: 29 start-page: 159 year: 1997 ident: R5-42-20110423 publication-title: Gen Pharmacol doi: 10.1016/S0306-3623(96)00410-7 – volume: 16 start-page: 137 year: 2001 ident: R8-42-20110423 publication-title: hock – volume: 92 start-page: 681 year: 2001 ident: R14-42-20110423 publication-title: Anesth Analg doi: 10.1097/00000539-200103000-00025 – volume: 28 start-page: 3019 year: 2000 ident: R25-42-20110423 publication-title: Crit Care Med doi: 10.1097/00003246-200008000-00057 – volume: 21 start-page: S19 year: 1993 ident: R1-42-20110423 publication-title: Crit Care Med doi: 10.1097/00003246-199302001-00005 – volume: 61 start-page: 496 year: 1996 ident: R3-42-20110423 publication-title: J Surg Res doi: 10.1006/jsre.1996.0153 – volume: 271 start-page: C1424 year: 1996 ident: R12-42-20110423 publication-title: Am J Physiol doi: 10.1152/ajpcell.1996.271.5.C1424 – volume: 100 start-page: 439 year: 1997 ident: R19-42-20110423 publication-title: J Clin Invest doi: 10.1172/JCI119551 – volume: 41 start-page: 131 year: 1996 ident: R7-42-20110423 publication-title: Brain Res Bull doi: 10.1016/0361-9230(96)00159-1 – volume: 118 start-page: 261 year: 1996 ident: R23-42-20110423 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1996.tb15397.x – volume: 67 start-page: 109 year: 1998 ident: R24-42-20110423 publication-title: Neuroendocrinology doi: 10.1159/000054305 – volume: 29 start-page: 189 year: 1980 ident: R13-42-20110423 publication-title: J Surg Res doi: 10.1016/0022-4804(80)90037-2 – volume: 108 start-page: 69 year: 2002 ident: R17-42-20110423 publication-title: J Surg Res doi: 10.1006/jsre.2002.6524 – volume: 23 start-page: 3886 year: 1994 ident: R15-42-20110423 publication-title: J Med Chem doi: 10.1021/jm00049a007 – volume: 375 start-page: 408 year: 1995 ident: R21-42-20110423 publication-title: Nature doi: 10.1038/375408a0 – volume: 821 start-page: 322 year: 1999 ident: R11-42-20110423 publication-title: Brain Res doi: 10.1016/S0006-8993(99)01124-5 – volume: 6 start-page: 79 year: 1996 ident: R4-42-20110423 publication-title: Shock doi: 10.1097/00024382-199608000-00001 – volume: 36 start-page: 735 year: 2002 ident: R26-42-20110423 publication-title: Free Radic Res doi: 10.1080/10715760290032557 – volume: 16 start-page: 304 year: 2001 ident: R16-42-20110423 publication-title: Shock doi: 10.1097/00024382-200116040-00013 – volume: 2 start-page: 581 year: 1996 ident: R10-42-20110423 publication-title: Nat Med doi: 10.1038/nm0596-581 – volume: 24 start-page: 298 year: 1996 ident: R2-42-20110423 publication-title: Crit Care Med doi: 10.1097/00003246-199602000-00020 – volume: 75 start-page: 2144 year: 2000 ident: R27-42-20110423 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2000.0752144.x |
SSID | ssj0001086 |
Score | 1.9599428 |
Snippet | In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer nii |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 212 |
SubjectTerms | Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animals Biological and medical sciences Blood Pressure Blood Pressure - drug effects Blotting, Western Calcium Calcium - physiology Cecum Cecum - injuries Cecum - physiology Cerebral Cortex Cerebral Cortex - metabolism Enzyme Inhibitors Enzyme Inhibitors - therapeutic use Heart Rate Heart Rate - drug effects Hemodynamics Hemodynamics - drug effects Interleukin-1 Interleukin-1 - metabolism Lysine Lysine - analogs & derivatives Lysine - therapeutic use Male Medical sciences Nervous System Diseases Nervous System Diseases - drug therapy Nervous System Diseases - etiology Nitric Oxide Nitric Oxide - metabolism Nitric Oxide Synthase Nitric Oxide Synthase - antagonists & inhibitors Nitric Oxide Synthase Type II Rats Rats, Wistar Shock, Septic Shock, Septic - complications Shock, Septic - physiopathology Tumor Necrosis Factor-alpha Tumor Necrosis Factor-alpha - metabolism Tyrosine Tyrosine - analogs & derivatives Tyrosine - metabolism |
Title | Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally induced septic shock in rats |
URI | https://cir.nii.ac.jp/crid/1573105976154161536 https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00000539-200407000-00042 https://www.ncbi.nlm.nih.gov/pubmed/15281532 https://www.proquest.com/docview/66750784 |
Volume | 99 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6l5cIFgXgFaNkDt-AQr9dJ9hhBUQHRHEil3Czb61UNrY3iWFB-CWd-Kd-sn4EiCodYiZPddTSf57H-ZoaxZ8IYejqlHBNNQkfOReyoRIWO1m5kYFImWtOG_vuT6fGpfLv214PB9x5rqdxG4_jblXkl_yNVnINcKUv2HyTbTooTeA_54ggJ43gtGX-wTWyI-4PIuoxTyoLCLUrk-Pxrqun0WRpZUhaxu0Yb20YmgXd4keuqFb0VY1RuRzpPilGWbylvcpNjSlvpstGM-rIgC9gwI_t9Ac4vHbs6PNeCKDLxqDiDkrWJMmFVJ6otcwu9CoezqBLB8KImI0XaWoZ3i1fLN9YolB_Tlhm0XC2ti11eVJyxdpNCtoTWepOiLTaxo4upi1zVHqnRxfWnPuYaxSp6NlrYBLrf1b9wPZvSMA6zxFampLRa1x0rqVxvLERn9JoH_b_YwpahCC8Pcbrn77EbYgavjNLI1x15iPpTNb0Y6T_U5Wyx_os_r77j-uxlaUpE3LCAFE3VROWqKAe_-ZITcaL4ZPMmet7P6ja7VYctfFFh8A4bJNld9qPFH2_xxyv8cYs_3uGPA3-8xh_v4-85B_o4oY8DfbxGH--jj_fQhyn51ejjFfq4RR_9jNB3j52-Plq9PHbqnh9OTHwEaAsZTYh1aSJlYE0i2CNtZp6hjQntKY0v5MTTCLx9N1IJwgkltWvgP5gQsbx3n-1neZY8ZDyUBsOlmYUqktNQKiH1zMz9SRj7IhbhkKlGHEFcF8SnviznAQXGEGUwcYPFyVHQiTKwogyEGDKvHfu5KgtzrVEHkDoWo6PrzzwKbmaIKaSNu6ZDdriDh27qGo1D9rQBSAAzQM_2gLW8LIIpAn94-3LIHlS46Y0Vc0yOxZ0dIAVVorW9TlhiZTUrHIC60oR49LeLecxudrf6E7a_3ZTJATz0bXRob5afzSDlNQ |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selective+inducible+nitric+oxide+inhibition+can+restore+hemodynamics%2C+but+does+not+improve+neurological+dysfunction+in+experimentally-induced+septic+shock+in+rats&rft.jtitle=Anesthesia+and+analgesia&rft.au=KADOI%2C+Yuji&rft.au=GOTO%2C+Fumio&rft.date=2004-07-01&rft.pub=Lippincott&rft.issn=0003-2999&rft.volume=99&rft.issue=1&rft.spage=212&rft.epage=220&rft_id=info:doi/10.1213%2F01.ane.0000118111.94913.22&rft.externalDBID=n%2Fa&rft.externalDocID=15913235 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-2999&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-2999&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-2999&client=summon |